US$ 21.48
does kaiser cover glp-1 drugs Zepbound? What you need to know
Description
Ozempic and other GLP-1 receptor agonists can increase insulin secretion, suppress glucagon release, slow digestion, and more

The neuroscience now explains why you can't shortcut the reward system without dimming the whole emotional landscape
CU Cancer Center member Bryan Haugen, MD, breaks down the science behind the FDA warning on the GLP-1 weight-loss medications.

And at what point should we all be on it?

Reduced risk of side effects
oral regimens), and trial endpoints better tuned to metabolic mechanisms
